Tatva Chintan Pharma

** Tatva Chintan Pharma Chem TATV.NS soars as much as 20% to 1,218.5 rupees, highest since June 21, 2024

** Chemical manufacturer reports 27.7% y/y rise in Q1 net profit; rev grows 10.8%

** Q1 EBITDA margin at 14.8% vs year-ago 12%

** Stock set to gain for 2nd week, up 1.5% so far this week

** Stock logs busiest session since listing on July 29, 2021, with more than 2.2 mln shares traded, 20.2x the 30-day moving avg

** Stock rated "buy" on avg; median PT is 820 rupees, per data compiled by LSEG

** TATV last up 17.7%, taking YTD gains to 14.2%

(Reporting by Meenakshi Maidas in Bengaluru)

(([email protected];))

July 24 (Reuters) - Tatva Chintan Pharma Chem Ltd TATV.NS:

• TATVA CHINTAN PHARMA CHEM LTD - RE-APPOINTS CHINTAN SHAH AS MANAGING DIRECTOR

Source text: ID:nBSECvsh4

Further company coverage: TATV.NS

(([email protected];))

** Shares of Tatva Chintan Pharma TATV.NS falls 10.6% to a record low of 821 rupees

** Specialty chemicals maker posts Q2 loss of 6.6 million rupees ($78,505.07) vs profit of 77.8 mln rupees a year ago

** TATV sees busiest day in more than a month, with over 183,000 shares traded

** Analysts' avg rating on stock is "hold" vs "buy" on peer Gujarat Fluorochemicals GUJL.NS - LSEG

** Median PT on TATV is 1,021 rupees - LSEG

** Stock down 49% YTD vs 12% gain in GUJL

($1 = 84.0710 Indian rupees)

(Reporting by Aleef Jahan in Bengaluru)

(([email protected]))

** Shares of Tatva Chintan Pharma Chem TATV.NS up 2.6% to 1002 rupees, its biggest intraday pct gain since Sept. 24

** Stock set to mark first day of gains after 4 straight sessions of losses

** Co says Gujarat's pollution watchdog temporarily revokes closure direction for its Bharuch plant, and that it is in the process of resuming operations

** Avg rating of analysts on stock is "Buy," same as that on peer Gujarat Fluorochemicals GUJL.NS - LSEG

** Their median PT is 1,020.5 rupees

** Stock down 39% YTD vs 8% gain in GUJL

(Reporting by Aleef Jahan in Bengaluru)

(([email protected]))

Tatva Chintan Pharma Chem Ltd TATV.NS:

• TATVA CHINTAN PHARMA CHEM - GUJARAT POLLUTION CONTROL BOARD REVOKED CLOSURE DIRECTION

• TATVA CHINTAN PHARMA CHEM - IN PROCESS OF RESUMING OPERATIONS AT PLANT IN GUJARAT

Source text for Eikon: ID:nNSE8WfBKt

Further company coverage: TATV.NS

Sept 13 (Reuters) - Tatva Chintan Pharma Chem Ltd TATV.NS:

• TATVA CHINTAN PHARMA CHEM LTD - GETS DIRECTION TO CLOSE OPERATIONS AT PLANT IN BHARUCH, GUJARAT

• TATVA CHINTAN PHARMA CHEM - GPCB ASKED TO SUBMIT BANK GUARANTEE OF 200,000 RUPEES

• TATVA CHINTAN PHARMA CHEM - FINANCIAL IMPACT OF ORDER NOT ASCERTAINABLE AT THIS POINT

Source text for Eikon: ID:nBSEbL9Vhp

Further company coverage: TATV.NS

(([email protected];;))

May 3 (Reuters) - Tatva Chintan Pharma Chem Ltd TATV.NS:

• DIVIDEND 2 RUPEES PER SHARE

Further company coverage: TATV.NS

(([email protected];))

** Shares of Ami Organics AMIO.NS up as much as 2.8% to 1,255 rupees; last up 1.7%

** The speciality chemicals maker on Friday approved raising 5 bln rupees ($59.9 mln) via qualified institutional placement (QIP) of shares

** Average rating of five analysts covering the stock is "buy"; median PT is 1,315 rupees - LSEG data

** Including session's moves, AMIO up ~11% this year, far outpacing rivals Privi Speciality Chemicals PIVI.NS and Tatva Chintan Pharma Chem TATV.NS, which are down between 7.1%-21.8%

($1 = 83.4300 Indian rupees)

(Reporting by Navamya Ganesh Acharya in Bengaluru)

(([email protected]; +91 8805175330 ;))

** Shares of Tatva Chintan Pharma Chem TATV.NS down 1.6% to record low of 1,162.80 rupees

** Reuters could not immediately determine the reason for stock move

** Stock poised for a third consecutive session of losses; eyes third straight week of decline, if trends hold

** Average rating of five analysts tracking TATV is "buy"; median PT is 1,487 rupees - LSEG data

** Including session's move, TATV is down 27.4% YTD

(Reporting by Navamya Ganesh Acharya in Bengaluru)

(([email protected]; +91 8805175330 ;))

Nov 10 (Reuters) - Tatva Chintan Pharma Chem Ltd TATV.NS:

• COMPANY'S ANKLESHWAR PLANT WILL BE TEMPORARILY CLOSED FOR PLANNED MAINTENANCE

• THERE WILL BE NO ADVERSE IMPACT ON OUR SUPPLY COMMITMENTS

• COMPANY HAS MAINTAINED SUFFICIENT RESERVE STOCK OF ITS PRODUCTS TO MEET OUR CUSTOMERS' REQUIREMENTS

• IN CASE OF SUDDEN REQUIREMENT, SAME SHALL BE MET FROM OUR DAHEJ PLANT

• MAINTENANCE SHUTDOWN IS SCHEDULED TO TAKE PLACE FROM 11 NOVEMBER 2023 TO 21 NOVEMBER 2023

Source text for Eikon: ID:nBSEbrSqM6

Further company coverage: TATV.NS

(([email protected];))

Nov 2 (Reuters) - Tatva Chintan Pharma Chem Ltd TATV.NS:

• INDIA'S TATVA CHINTAN PHARMA CHEM LTD SEPT-QUARTER CONSOL NET PROFIT 77.8 MILLION RUPEES VERSUS PROFIT 71.1 MILLION RUPEES

• TATVA CHINTAN PHARMA CHEM LTD SEPT-QUARTER CONSOL REVENUE FROM OPERATIONS 966.7 MILLION RUPEES VERSUS 900.9 MILLION RUPEES

Source text for Eikon: ID:nBSE5sT2r5

Further company coverage: TATV.NS

(([email protected];))

Aug 4 (Reuters) - Tatva Chintan Pharma Chem Ltd TATV.NS:

• INDIA'S TATVA CHINTAN PHARMA CHEM JUNE-QUARTER CONSOL NET PROFIT 95 MILLION RUPEES VERSUS PROFIT 98 MILLION RUPEES

• TATVA CHINTAN PHARMA CHEM JUNE-QUARTER CONSOL REVENUE FROM OPERATIONS 1.14 BILLION RUPEES VERSUS 884 MILLION RUPEES

Source text for Eikon: ID:nBSE5x05cW

Further company coverage: TATV.NS

(([email protected];;))

** Shares of Tatva Chintan Pharma Chem Ltd TATV.NS fall as much as 7.33%, their steepest intraday pct decline in nearly six months, to 1,695 rupees

** Speciality chemicals maker reports fall in net profit to 169.5 mln rupees ($2.1 mln) for March-qtr vs 175.1 mln rupees YoY; rev rose 26.4%

** Brokerage Nirmal Bang ("sell") says majority of TATV's portfolio is not protected, expects earnings growth to moderate in declining pricing scenario

** ICICI Securities cuts earnings estimates for FY2024 and FY2025 after results, citing near-term margin weakness

** About 44,319 shares change hands as of 10:47 a.m. IST, twice the 30-day avg - Refinitiv data

** Of five analysts tracking TATV, three maintain "buy", one suggests "sell" and one recommends "hold"; median TP is 2,400 rupees

($1 = 81.7120 Indian rupees)

(Reporting by Bharath Rajeswaran in Bengaluru)

(([email protected]; +91 9769003463))

May 5 (Reuters) - Tatva Chintan Pharma Chem Ltd TATV.NS:

• MAR-QUARTER CONSOL NET PROFIT 169.5 MILLION RUPEES VERSUS PROFIT 175.1 MILLION RUPEES

• MAR-QUARTER CONSOL REVENUE FROM OPERATIONS 1.25 BILLION RUPEES VERSUS 985.3 MILLION RUPEES

• DIVIDEND OF 2 RUPEES PER SHARE

Source text for Eikon: ID:nBSE3G6wRl

Further company coverage: TATV.NS

(([email protected];))